Goingtomeet.com Press

This event will provide essential perspectives from both industry, regulatory and scientific perspectives in terms of what are the factors preventing biologics from progressing further in development and the vital elements of a successful early stage strategy for biologic studies.

Attendees will achieve an advanced understanding of how to incorporate the specific biologic requirements into the strategic & operational planning for an early phase clinical trial that provides the best opportunity to save time, reduce risk, reduce costs and maximise product value.

Why attend?

* Meet experts directly involved in biologic trial design and implementation
* Learn about the specific regulatory guidance and level of proof required to satisfy the governing bodies.
* Understand the perspectives of all stakeholder involved, i.e. regulators, sponsors, CROs, SMOs, central labs and experienced biologic investigators.
* Come to benchmark, share experience and help to develop a best-practice approach to biologic clinical development.
* Build stronger relationships upon a better understanding of the challenges faced by each group, who are all vital to the planning and implementation of the study

Who will benefit

* Experienced executives from Pharma and Biotechs involved in Biologic development
* VPs, Professors, Senior Directors and Managers
* Discovery
* Pre-Clinical Development
* Exploratory development
* Early phase clinical development
* Clinical science
* Clinical Operations
* Clinical pharmacology
* PK & PD
* Drug safety & biomarkers
* Translational medicine
* Regulatory affairs

Agenda Request

To request the full agenda please follow the link:

https://www.nextlevelpharma.com/events/request_agenda/advanced_biologics_from_the_lab_to_the_clinic

Contact Details:

For Booking Information:

Tel: +421 232 662 621

Fax: +421 232 662 622

Email: erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com

The ability to accurately predict adverse events related to areas like cardiology, nephrology, neurology, haematology and hepatology is extremely exciting. Validated safety biomarkers provide the opportunity for smarter and earlier decision making in R&D, meaning project „kill“ decisions are made quicker, later-stage projects become less risky and hundreds of millions of dollars can be saved.

This webinar will summarise what are the most innovative recent scientific developments and the most promising regulatory initiatives, as well as providing a platform for partnering amongst the pharma, biotech, diagnostics and academic sectors.

Why attend?

• Understand the regulatory requirements to demonstrate safety through biomarkers.
• Make partnerships and alliances with biomarker R&D experts.
• Gain access to the latest successful biomarker development case studies.
• Review multi-stakeholders perspectives: pharma, regulators, research institutes, academia & solution providers.
• Learn how to integrate biomarker knowledge in monitoring safety in drug development to reduce risk.
• Identify and understand better, advanced cardiac, renal, hepatological and neurological risk markers.
• Discover cutting-edge approaches for identification and development of new markers.

Who will benefit:

Pharmaceutical, Biotech, Diagnostic & Academic research organisations:
CEOs / Vice-Presidents / Heads / CSOs / Managers / Professors and Scientists involved in: R&D, drug safety & pharmacovigilance, biomarker discovery/validation, molecular diagnostics, pharmacogenomics/genetics/proteomics, translational medicine, clinical science and development, molecular imaging, pre-clinical development, modeling and simulation, pharmacology, pharmacokinetics/pharmacodynamics

Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads

 

Agenda Request

To request the full agenda please follow the link:

https://www.nextlevelpharma.com/events/request_agenda/safety_biomarkers_in_drug_development

Contact Details:

For Booking Information:

Tel: +421 232 662 621

Fax: +421 232 660 395
Email: erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com

• • Successful Gene Expression Analysis using real-time PCR
  • Profiling technologies: multivariate and multiway expression profiling, temporal expression profiling and spatiotemporal maps
  • Other technologies: High resolution melt, Immuno PCR, Methylation sensitive PCR, SNP analysis, microRNA detection and Multiplex technologies
  • Development of clinical diagnostics and clinical Development – use in therapeutic areas such as cancer and infectious diseases
  • Bioinformatics
  • Data management: software applications, data mining, data visualization, biostatistics, multivariate statistics
    
  • Assay optimisation and validation strategies
  • New applications of qPCR- High throughput applications, Real-time RT-PCR arrays and Digital PCR
  • The discovery of Biomarkers: Disease markers, Tissue specific markers, Cancer markers, Stem cells, Differentiation markers and Cancer stem cells
  • The potential and use of qPCR reagents and instrumentation

Oxford Global Conferences is proud to present qPCR Congress 2009 (www.qpcr-congress.com), which is to be held on the 16th & 17th November 2009 in London. The congress is the single most focused event in Europe dedicated to key technological and scientific trends & advances in qPCR in the pharmaceutical and biotech industry, as well as academic institutions. There is also a post conference workshop on Biostatistics on the 18th November.

 

This conference explores effective strategies, technologies and applications of qPCR in accelerating drug discovery and the development of clinical diagnostics. Over three days, the event will attract over 120 senior-level decision makers working in discovery, biomarkers, gene expression, molecular biology, and clinical & diagnostics development and bioinformatics & data management from the UK, Europe and US.  This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.

 

THE EVENT

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 45 speakers will present a full conference programme covering the following key topics include:

 

Day 16th November

Stream 1: qPCR in Diagnostics and Molecular Markers as well as Novel Technical Approaches

Stream 2: Bioinformatics and Data Management

Day 2 17th November

Stream 1: qPCR in Drug Discovery and Development

Stream 2: Next Generation Sequencing High Throughput Sequencing Platforms

 

Day 3 18th November: Post Conference Workshop – Biostatistics

 

WHO ATTENDS?

Delegates are pre-qualified dependent on budget, responsibility and seniority.  Delegates are senior-level decision makers, from major pharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:

 

Drug Discovery	Biomarkers	Bioinformatics	Clinical Diagnostics
Principal Investigators	Molecular Profiling	Clinical Development	qPCR
Gene Expression
Toxicology	Translational Science	Biochemistry	Genomics
Biostatistics	High throughput Technologies	Data Management	Cell Biology

 

YOUR NETWORKING OPPORTUNITIES

Meet face-to-face with leading solution providers and senior-level industry peers through a series of formal and informal networking opportunities.  Using our online appointment system, you are able to view the full profiles of all solution provides before the event.  In addition you have the chance to pre-arrange one-to-one meetings with them, giving you the opportunity to discuss technologies, services and solutions that address your key business needs.  Categories of solution providers include:

 

Real-Time PCR Reagents & Instrumentation	qPCR technologies	Screening Technologies
Gene Expression Services	RNAi Applications	Bioinformatics/Biostatistics Solutions
Molecular & Expression Profiling	High Throughput Sequencing	Data Management Methods
Multiplex Technologies	Sampling Technologies	Multimarker Diagnostics

 

 

Special discounts are available by quoting qPCRDEL09. For information on sponsorship and registration please email info@oxfordglobal.co.uk or call +44(0) 1865 304925 www.qpcr-congress.com.

 

 

Oxford Global Conferences is proud to present the 2nd Annual Proteins Congress 2009, which is to be held on the 29th & 30th October in Berlin. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in Proteins in the pharmaceutical and biotech industry, as well as academic institutions. It will also be co-located with our GPCR Congress

With the ever-expanding protein therapeutic market, there is a need for the bio/pharma industry to reassess the technology, discovery and delivery trends.  Protein expression & characterisation systems are rapidly evolving, and there is more pressure to harvest larger, purer quantities of product to support research pipelines. More efficient methods are also needed to identify and analyse proteins involved in disease populations with the aim to discover novel diagnostic tools and treatments. The conference also looks at effective strategies in protein assays and microarrays and data mining in discovery.

Over two days, the 2 events will attract over 150 senior-level decision makers working in Proteins development from the UK, Europe and US.  This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme.

Day One

Protein Expression, Purification and Characterization: Examines different expression systems including Bacman technology in mammalian cells through the use of Baculovirus, as well as purification and characterization processes, new cell line development, and how to overcome immunogencity problems

Vaccines, Novel Technologies & IP and Outsourcing Issues: Explores various techniques and technologies involved with Proteins and Vaccines and also a strategic overview of various IP & outsourcing issues.

Day Two

Biotherapeutics: Protein engineering technologies for next generation biotherapeutics including focus on increasing half life, alternative scaffolds and biosimilars

Protein Structure & Production: Analysis of protein structure from a structural biology angle as well as focus on Protein Production solutions and techniques

Who you will meet

Delegates are pre-qualified dependent on budget, responsibility and seniority.  Delegates are senior-level decision makers, from major pharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:

Proteins   Protein Engineering  Structural Chemistry  Crystallography  Molecular Research

Proteomics Protein Science  Structural Biology    Bioformulations  Biopharmaceutical Development

Discovery Protein Production  Bioinformatics Biomarkers  Biologics Research

Biotherapeutics  Medical Science Biochemistry  Expression Systems  Technology Development

THE NEW EVENT FORMAT: NETWORKING AND BUSINESS MEETING OPPORTUNITIES

Meet face-to-face with leading solution providers and senior-level industry peers through a series of formal and informal networking opportunities.  Using our online appointment system, you are able to view the full profiles of all solution provides before the event.  In addition you have the chance to pre-arrange one-to-one meetings with them, giving you the opportunity to discuss technologies, services and solutions that address your key business needs.  Categories of solution providers include:

Protein Analysis  Expression Vectors  Protein Engineering Solutions  Protein Chip & Microarrays

Lyopllization  Phage Display  Protein & Antibody Labelling High Throughput Applications / Platforms

Purification Sequencing Plasma Protein Profiles  Protein Expression Systems

Sequencing  Immunogenicity  Diagnostics   Protein Protein Interactions

Transcription Regulation Protein DetectionCell Signalling  Parallel Quantitative Biology

THE ORGANISERS

Oxford Global Conferences, produce cutting edge congresses and summits in the Life Sciences sector. Focusing on summits,

Conferences and unique congress formats, our success is unrivalled in the production of high calibre events that offer tailored

knowledge-sharing, industry solutions and networking opportunities. A list of upcoming events is below:-

2nd Annual Proteins Congress, October 29th-30th 2009, Berlin Germany

GPCR Congress, October 29th-30th 2009, Berlin Germany

QPCR Congress, 16-17 November 2009, London

5th Annual Biomarkers Congress, February , 2010, Midland Hotel, Manchester, UK

2nd Annual Drug Development Summit, April 2010,One America Square, London, UK

11th Annual Drug Discovery Leaders Summit, June 2010

8th Annual Pharma Technology and IT Summit, June 2010

Special discounts are available by quoting “PCDEL09�. For information on sponsorship and registration please email info@oxfordglobal.co.uk or call +44(0) 1865 304925 www.proteins-congress.com.

Following the success of the Advances in Synthetic Chemistry conference last year, Select Biosciences is pleased to announce this year’s meeting.

Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organising a two day event, gathering some of the most influential players in the field from Europe, America and across the globe.

The agenda includes world leading research from renowned speakers including:

Mark Bradley,Professor, University of Edinburgh
Oliver Kappe, Professor, Karl-Franzens-University Graz
Mark Bagley, Lecturer, University of Cardiff
Ferenc Darvas, President, Thales Nanotechnology
Jim Thomas, Professor, Manchester University
Michael Greaney, Professor, Edinburgh University
Bruno Linclau, Senior Lecturer, University of Southampton
Stephen Clark, Head of Organic Chemistry, Glasgow University
Villem Verboom, Associate Professor, University of Twente
Erik Van der Eycken, Professor, University of Leuven
Irena Stara, Project Leader, Institute of Organic Chemistry and Biochemistry Prague
Semen Zlotsky, Professor, Ufa State Aviation Technical University
Mehul Tathagar, Research Scientist, DSM

And many more…

To guarantee a high attendance at this exciting event, Select Biosciences will maintain their traditional low registration fees and group booking discounts.

Full conference passes include admission to all sessions and the exhibition, as well as conference documentation.
Lunch, coffee breaks and the drinks reception provide ample time for networking and to continue discussions from the question and answer sessions.

The conferences division of Select Biosciences Ltd is focused on organising specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.

www.selectbiosciences.com

For further information contact Sara Sharpe
s.sharpe@selectbiosciences.com